---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284789186.md"
description: "NovoCure shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY26 sales guidance with its midpoint above estimates."
datetime: "2026-04-30T13:26:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284789186.md)
  - [en](https://longbridge.com/en/news/284789186.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284789186.md)
---

# 

NovoCure shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY26 sales guidance with its midpoint above estimates.

### Related Stocks

- [NVCR.US](https://longbridge.com/en/quote/NVCR.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)

## Related News & Research

- [Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients](https://longbridge.com/en/news/287144318.md)
- [Orthofix Medical updates 2026 outlook after CMS Medicare cuts for bone growth stimulators](https://longbridge.com/en/news/287216169.md)
- [BUZZ-Dexcom climbs on plans to revamp board panel](https://longbridge.com/en/news/286583878.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [West Pharmaceutical Says Making Progress In Restoring Global Operations After Cyberattack](https://longbridge.com/en/news/286605804.md)